Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

China flag China · Delayed Price · Currency is CNY
16.32
-0.08 (-0.49%)
Mar 11, 2026, 3:04 PM CST
21.61%
Market Cap 2.62B
Revenue (ttm) 257.07M
Net Income (ttm) 57.94M
Shares Out 160.00M
EPS (ttm) 0.35
PE Ratio 46.96
Forward PE n/a
Dividend 0.30 (1.88%)
Ex-Dividend Date May 28, 2025
Volume 2,339,800
Average Volume 3,789,215
Open 16.00
Previous Close 16.40
Day's Range 16.00 - 16.45
52-Week Range 11.13 - 20.36
Beta 0.41
RSI 56.06
Earnings Date Apr 20, 2026

About SHE:300519

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China. [Read more]

Sector Healthcare
Founded 1998
Employees 316
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300519
Full Company Profile

Financial Performance

In 2024, SHE:300519's revenue was 267.66 million, a decrease of -1.01% compared to the previous year's 270.40 million. Earnings were 50.39 million, a decrease of -21.70%.

Financial Statements

News

There is no news available yet.